Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Hemodynamic Changes With Morphine Versus Esmolol as an Adjuvant Agent During Induction of Anaesthesia
NCT06065956Phase 2Completed
- Sponsor
- PNS Shifa
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial comparing Morphine group with Esmolol group (2 arms). Primary endpoints: Blood pressure at 6 months and Pulse rate at 6 months. Started Aug 2022; status: completed.
02
Drugs
morphineesmolol
Beyond the preview
Go deeper on NCT06065956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065956.